Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Usana Health Sciences (USNA) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Usana Health Sciences (USNA) over the last 14 years, with Q3 2025 value amounting to $18.7 million.

  • Usana Health Sciences' Shares Outstanding (Diluted Average) fell 265.89% to $18.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year decrease of 265.89%. This contributed to the annual value of $19.2 million for FY2024, which is 94.6% down from last year.
  • Usana Health Sciences' Shares Outstanding (Diluted Average) amounted to $18.7 million in Q3 2025, which was down 265.89% from $18.8 million recorded in Q2 2025.
  • Over the past 5 years, Usana Health Sciences' Shares Outstanding (Diluted Average) peaked at $21.3 million during Q1 2021, and registered a low of $18.7 million during Q3 2025.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $19.3 million (2022), whereas its average is $19.5 million.
  • Per our database at Business Quant, Usana Health Sciences' Shares Outstanding (Diluted Average) tumbled by 603.42% in 2022 and then soared by 33.57% in 2023.
  • Quarter analysis of 5 years shows Usana Health Sciences' Shares Outstanding (Diluted Average) stood at $20.6 million in 2021, then decreased by 6.11% to $19.3 million in 2022, then grew by 0.18% to $19.3 million in 2023, then decreased by 0.95% to $19.2 million in 2024, then dropped by 2.56% to $18.7 million in 2025.
  • Its last three reported values are $18.7 million in Q3 2025, $18.8 million for Q2 2025, and $19.1 million during Q1 2025.